Has Craig Mahoney, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,739 in general payments to Craig Mahoney, MD across 121 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Craig Mahoney, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Craig Mahoney, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Craig Mahoney, MD

Orthopaedic Surgery · Des Moines, IANPI 1770544165

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,433 of the $10,739 with a category attached, or 69.2%. 15 manufacturers reported payments, led by Stryker at 28.7% of the total. Reporting peaked in 2021 at $2,812 and has fallen 65.2% since, to $980 in 2025.

$10,739in general payments, 2019–2025

Across 121 payments — averaging $88.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$3K
Zimmer Biomet$3K
Heron Therapeutics, Inc.$2K
Smith+Nephew$1K
Johnson & Johnson$376
Davol Inc.$323
plus $595 from 9 others

$11,850in research payments, 2019–2025

Across 3 payments — averaging $3950.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Smith+Nephew$12K
Medical Device Business Services, Inc.$250

What the payments were for

Consulting fees$2,00019%
Travel & lodging$7797%
Food & beverage$7,43369%
Education$5275%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	38	$3,078
Zimmer Biomet	32	$2,929
Heron Therapeutics, Inc.	2	$2,053
Smith+Nephew	21	$1,385
Johnson & Johnson	14	$376
Davol Inc.	2	$323
Wardlow Enterprises	1	$157
Encore Medical, LP	1	$128
Pacira Therapeutics, Inc.	3	$123
Dynasplint Systems Inc.	1	$79
Sanara Medtech Inc.	1	$32
Novo Nordisk	2	$30
Pacira Pharmaceuticals Incorporated	1	$20
Pfizer	1	$14
Mallinckrodt Enterprises LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MAKO$2,107
Zynrelef$2,000
ROSA$466
Persona$441
PICO 7 Single Use Negative Pressure Wound Therapy$317
Navio Surgical System$256
Comprehensive Shoulder System$222
ARISTA AH FLEXITIP$175
T-Fix$170
Journey II BCS$170
REDAPT Revision Hip System$170
1788$167
ARISTA$149
LENS 4K$149
Legion$147
REGENESORB$147
REAL INTELLIGENCE$145
ROSA-Knee$129
DJO SURGICAL$128
CORI$123

How this compares

$10,739 in reported general payments places this provider in the 80th percentile of 219 orthopaedic surgery providers in Iowa.

See all orthopaedic surgery providers in Iowa →

Medicare billing

Part B allowed, 2024

$340,746

Medicare patients

765

Services billed

11,954

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cephalexin	233	$890
Meloxicam	118	$161
Clindamycin Hcl	48	$92
Ondansetron OdtOndansetron	11	$86
Amoxicillin	15	$4

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Des Moines

Brett RosenthalDes Moines$42K
Justin KhoriatyDes Moines$36K
Joseph GallesDes Moines$12K
John CallaghanIowa City$23.3M
Brian AdamsIowa City$865K
Cesar de Cesar NettoIowa City$693K
Lynn NelsonBelmond$285K
Robert WestermannIowa City$182K
Joseph BuckwalterIowa City$132K
Brendan PattersonIowa City$122K

See the full list for Iowa →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →